BML-259

• Target:

  CDK

• Related Pathways:

  Cell Cycle/Checkpoint

• Purity:

  0.9984

• Bioactivity:

  BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

• Smiles:

  CC(C)c1cnc(NC(=O)Cc2ccccc2)s1

• Molecular Formula:

  C14H16N2OS

• Molecular Weight:

  260.35

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  267654-00-2